methazole has been researched along with Metabolic Syndrome in 1 studies
methazole: structure
probe : A role played by a molecular entity used to study the microscopic environment.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) can be diagnosed early by noninvasive ultrasonography; however, the cost-effectiveness of ultrasonography screening with intensive weight reduction program in metabolic syndrome patients is not clear." | 1.46 | Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients. ( Apisarnthanarak, P; Chaiyakunapruk, N; Charatcharoenwitthaya, P; Charoensak, A; Phisalprapa, P; Srivanichakorn, W; Supakankunti, S; Washirasaksiri, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phisalprapa, P | 1 |
| Supakankunti, S | 1 |
| Charatcharoenwitthaya, P | 1 |
| Apisarnthanarak, P | 1 |
| Charoensak, A | 1 |
| Washirasaksiri, C | 1 |
| Srivanichakorn, W | 1 |
| Chaiyakunapruk, N | 1 |
1 other study available for methazole and Metabolic Syndrome
| Article | Year |
|---|---|
Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.
Topics: Cohort Studies; Cost-Benefit Analysis; Decision Trees; Humans; Markov Chains; Metabolic Syndrome; Mi | 2017 |